Vaginal Carcinoma clinical trials
25 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- HPV Vaccine, Imiquimod, and Metformin Combination Trial
- E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
- E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers
- Pomalidomide and Nivolumab in People With Virus-Associated Malignancies With or Without HIV
- Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin
- Using Reiki Therapy to Improve Symptoms Associated With Brachytherapy in Patients With Gynecological Malignancies
- Image-Guided Gynecologic Brachytherapy
- At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
- Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers
- Screening Women With Prior HPV for Anal Neoplasia
- DESTINY-PANTUMOUR04
- NYSCF Scientific Discovery Biobank
- A Multi Center Study of Sexual Toxicities After Radiotherapy
- Integrated Cancer Repository for Cancer Research
- Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
- Using Virtual Reality Technology to Improve Patient Experience and Quality of Care During Brachytherapy
- BOLSTER: Learning New Skills to Thrive
- Vaginal Dilator Therapy After Pelvic Radiation
- Vaginal DHEA to Improve Vaginal Health After Radiation for Women With Gynecologic, Anal or Rectal Cancer
- ASk Questions in GYnecologic Oncology (ASQ-GYO)
- Oral 5 Strain Probiotic for GI Toxicity Mitigation During Pelvic Radiation
- Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)
- Pre-Rehabilitation for Female Patients Undergoing Pelvic Radiotherapy
- Feasibility of Addressing Sexual Dysfunction in Women with Breast and Gynecologic Cancers with a Novel Mobile Application
- Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Vaginal Carcinoma” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.